Stock Events

Stock Events

Karyopharm Therapeutics (KPTI) Q2 2025 Earnings

12MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-4.42

-3.01

-1.61

-0.2

Details

Expected EPS

-4.419286

Actual EPS

-2.77

Surprise EPS

1.65

Surprise Percent

+37.32%

Description

Karyopharm Therapeutics (KPTI) has reported earnings of -2.77 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.